
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
Sujay Paul, Luis Alberto Bravo-Vázquez, Paula Reyes‐Pérez, et al.
Virus Research (2021) Vol. 308, pp. 198631-198631
Open Access | Times Cited: 56
Sujay Paul, Luis Alberto Bravo-Vázquez, Paula Reyes‐Pérez, et al.
Virus Research (2021) Vol. 308, pp. 198631-198631
Open Access | Times Cited: 56
Showing 26-50 of 56 citing articles:
A Brief Review on the Regulatory Roles of MicroRNAs in Cystic Diseases and Their Use as Potential Biomarkers
Luis M. Ruiz‐Manriquez, S Pacheco, Daniel Medina‐Gomez, et al.
Genes (2022) Vol. 13, Iss. 2, pp. 191-191
Open Access | Times Cited: 11
Luis M. Ruiz‐Manriquez, S Pacheco, Daniel Medina‐Gomez, et al.
Genes (2022) Vol. 13, Iss. 2, pp. 191-191
Open Access | Times Cited: 11
MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response
Tânia R. Dias, Francisca Dias, Ana Luísa Teixeira, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2279-2279
Open Access | Times Cited: 11
Tânia R. Dias, Francisca Dias, Ana Luísa Teixeira, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2279-2279
Open Access | Times Cited: 11
Screening for differentially expressed microRNAs in BALF and blood samples of infected COVID‐19 ARDS patients by small RNA deep sequencing
Reza Najafipour, Davood Mohammadi, Zohreh Estaki, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 11
Open Access | Times Cited: 11
Reza Najafipour, Davood Mohammadi, Zohreh Estaki, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 11
Open Access | Times Cited: 11
Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature
Sara Redenšek, David Vogrinc, Katja Goričar, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 6
Sara Redenšek, David Vogrinc, Katja Goričar, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 6
Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease
Alexandra Ioana Moatăr, Aimée Rodica Chiş, Cătălin Marian, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9239-9239
Open Access | Times Cited: 10
Alexandra Ioana Moatăr, Aimée Rodica Chiş, Cătălin Marian, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9239-9239
Open Access | Times Cited: 10
Effect of Age, Sex, and COVID-19 Vaccination History on All-Cause Mortality: Unexpected Outcomes in a Complex Biological and Social System
Rod Jones, Andrey Ponomarenko
(2023)
Open Access | Times Cited: 5
Rod Jones, Andrey Ponomarenko
(2023)
Open Access | Times Cited: 5
Small non-coding RNAs encoded by RNA viruses: old controversies and new lessons from the COVID-19 pandemic
Carolina Ruivinho, Margarida Gama‐Carvalho
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 5
Carolina Ruivinho, Margarida Gama‐Carvalho
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 5
Advances in Targeting ACE2 for Developing COVID-19 Therapeutics
Sanika Suvarnapathaki, Divya Chauhan, Angelina Nguyen, et al.
Annals of Biomedical Engineering (2022) Vol. 50, Iss. 12, pp. 1734-1749
Open Access | Times Cited: 9
Sanika Suvarnapathaki, Divya Chauhan, Angelina Nguyen, et al.
Annals of Biomedical Engineering (2022) Vol. 50, Iss. 12, pp. 1734-1749
Open Access | Times Cited: 9
Tumor Suppressor microRNAs in Gastrointestinal Cancers: A Mini-Review
Ganesan Jothimani, Meenu Bhatiya, Surajit Pathak, et al.
Recent Advances in Inflammation & Allergy Drug Discovery (2022) Vol. 16, Iss. 1, pp. 5-15
Closed Access | Times Cited: 8
Ganesan Jothimani, Meenu Bhatiya, Surajit Pathak, et al.
Recent Advances in Inflammation & Allergy Drug Discovery (2022) Vol. 16, Iss. 1, pp. 5-15
Closed Access | Times Cited: 8
microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An in Vitro Model
Elif Damla Arısan, D. Alwyn Dart, Guy H. Grant, et al.
ACS Omega (2022) Vol. 7, Iss. 42, pp. 38003-38014
Open Access | Times Cited: 8
Elif Damla Arısan, D. Alwyn Dart, Guy H. Grant, et al.
ACS Omega (2022) Vol. 7, Iss. 42, pp. 38003-38014
Open Access | Times Cited: 8
In silico analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs
Neha Periwal, Urvashi Bhardwaj, Sankritya Sarma, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 8
Neha Periwal, Urvashi Bhardwaj, Sankritya Sarma, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 8
mRNA COVID-19 Vaccines—Facts and Hypotheses on Fragmentation and Encapsulation
Jacques Demongeot, Cécile Fougère
Vaccines (2022) Vol. 11, Iss. 1, pp. 40-40
Open Access | Times Cited: 8
Jacques Demongeot, Cécile Fougère
Vaccines (2022) Vol. 11, Iss. 1, pp. 40-40
Open Access | Times Cited: 8
COVID-19-Related Age Profiles for SARS-CoV-2 Variants in England and Wales and States of the USA (2020 to 2022): Impact on All-Cause Mortality
Rod Jones, Andrey Ponomarenko
Infectious Disease Reports (2023) Vol. 15, Iss. 5, pp. 600-634
Open Access | Times Cited: 4
Rod Jones, Andrey Ponomarenko
Infectious Disease Reports (2023) Vol. 15, Iss. 5, pp. 600-634
Open Access | Times Cited: 4
Dysregulated thrombospondin 1 and miRNA-29a-3p in severe COVID-19
In Soo Kim, Sung‐Gwon Lee, Seul Gi Shin, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
In Soo Kim, Sung‐Gwon Lee, Seul Gi Shin, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Salivary Antiviral and Antibacterial Properties in the Encounter of SARS-CoV-2
Nooshin Mohtasham, Rahimeh Bargi, Alieh Farshbaf, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 27, pp. 2140-2148
Closed Access | Times Cited: 3
Nooshin Mohtasham, Rahimeh Bargi, Alieh Farshbaf, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 27, pp. 2140-2148
Closed Access | Times Cited: 3
Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection
Yousef Rasmi, Shima Hatamkhani, Roya Naderi, et al.
Acta Histochemica (2022) Vol. 124, Iss. 5, pp. 151908-151908
Open Access | Times Cited: 5
Yousef Rasmi, Shima Hatamkhani, Roya Naderi, et al.
Acta Histochemica (2022) Vol. 124, Iss. 5, pp. 151908-151908
Open Access | Times Cited: 5
Viral and Host Small RNA Response to SARS-CoV-2 Infection
Guihua Sun, Qi Cui, Gustavo Garcia, et al.
Microbiology Research (2022) Vol. 13, Iss. 4, pp. 788-808
Open Access | Times Cited: 5
Guihua Sun, Qi Cui, Gustavo Garcia, et al.
Microbiology Research (2022) Vol. 13, Iss. 4, pp. 788-808
Open Access | Times Cited: 5
Prediction Models based on miRNA-disease Relationship: Diagnostic Relevance to Multiple Diseases Including COVID-19
Añil Sharma, Varruchi Sharma, Mukesh Yadav, et al.
Current Pharmaceutical Biotechnology (2022) Vol. 24, Iss. 10, pp. 1213-1227
Closed Access | Times Cited: 5
Añil Sharma, Varruchi Sharma, Mukesh Yadav, et al.
Current Pharmaceutical Biotechnology (2022) Vol. 24, Iss. 10, pp. 1213-1227
Closed Access | Times Cited: 5
Host microRNA interactions with the SARS-CoV-2 viral genome 3’-untranslated region
Caleb J. Frye, Caylee L. Cunningham, Mihaela‐Rita Mihailescu
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Caleb J. Frye, Caylee L. Cunningham, Mihaela‐Rita Mihailescu
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Increased Serum Mir-150-3p Expression Is Associated with Radiological Lung Injury Improvement in Patients with COVID-19
L Buéno, Layde R. Paim, Eduarda O. Z. Minin, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1363-1363
Open Access | Times Cited: 4
L Buéno, Layde R. Paim, Eduarda O. Z. Minin, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1363-1363
Open Access | Times Cited: 4
HYGIEIA: HYpothesizing the Genesis of Infectious Diseases and Epidemics through an Integrated Systems Biology Approach
Bradley Ward, Jean Cyr Yombi, Jean‐Luc Balligand, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1373-1373
Open Access | Times Cited: 4
Bradley Ward, Jean Cyr Yombi, Jean‐Luc Balligand, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1373-1373
Open Access | Times Cited: 4
Illuminating the pathogenic role of SARS-CoV-2: Insights into competing endogenous RNAs (ceRNAs) regulatory networks
Mahsa Aghajani Mir
Infection Genetics and Evolution (2024) Vol. 122, pp. 105613-105613
Open Access
Mahsa Aghajani Mir
Infection Genetics and Evolution (2024) Vol. 122, pp. 105613-105613
Open Access
Macrophage Activation Syndrome in Coinciding Pandemics of Obesity and COVID-19: Worse than Bad
Ayşe Başak Engin, Doruk Engin, Atilla Engin
Advances in experimental medicine and biology (2024), pp. 919-954
Closed Access
Ayşe Başak Engin, Doruk Engin, Atilla Engin
Advances in experimental medicine and biology (2024), pp. 919-954
Closed Access
Circulatory microRNAs as potential biomarkers for different aspects of COVID-19
Mahsan Zali, Mona Sadat Larijani, Anahita Bavand, et al.
Archives of Virology (2024) Vol. 170, Iss. 1
Closed Access
Mahsan Zali, Mona Sadat Larijani, Anahita Bavand, et al.
Archives of Virology (2024) Vol. 170, Iss. 1
Closed Access
Computational pharmacology: New avenues for COVID-19 therapeutics search and better preparedness for future pandemic crises
Austė Kanapeckaitė, Asta Mažeikienė, Liesbet Geris, et al.
Biophysical Chemistry (2022) Vol. 290, pp. 106891-106891
Open Access | Times Cited: 3
Austė Kanapeckaitė, Asta Mažeikienė, Liesbet Geris, et al.
Biophysical Chemistry (2022) Vol. 290, pp. 106891-106891
Open Access | Times Cited: 3